Neuland Laboratories Ltd
NSE:NEULANDLAB

Watchlist Manager
Neuland Laboratories Ltd Logo
Neuland Laboratories Ltd
NSE:NEULANDLAB
Watchlist
Price: 13 563 INR -2.42% Market Closed
Market Cap: 174B INR

Operating Margin

16.4%
Current
Declining
by 4%
vs 3-y average of 20.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
16.4%
=
Operating Income
₹2.5B
/
Revenue
₹15.3B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
16.4%
=
Operating Income
₹2.5B
/
Revenue
₹15.3B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Neuland Laboratories Ltd
NSE:NEULANDLAB
173.5B INR
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
273.2B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.7B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
No Stocks Found

Market Distribution

Higher than 77% of companies in India
Percentile
77th
Based on 5 437 companies
77th percentile
16.4%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Neuland Laboratories Ltd
Glance View

Neuland Laboratories Ltd., with its roots firmly planted in the bustling pharmaceutical sector of India, presents a captivating narrative of innovation and strategic growth. Founded in 1984 by Dr. D.R. Rao, the venture initially embarked on its journey by manufacturing Active Pharmaceutical Ingredients (APIs), essential components that power numerous medical treatments. Situated in Hyderabad, the company swiftly carved out a niche by focusing on complex and high-value APIs, earning a reputation for quality and reliability. This strategy enabled Neuland to establish long-standing relationships with prominent generic pharmaceutical companies across the globe. As the world of pharmaceuticals evolved, so did Neuland's approach to business. The company shifted gears to not just produce APIs but also ventured into Contract Research and Manufacturing Services (CRAMS), capitalizing on the growing demand for customized pharmaceutical development and production services. This not only diversified their revenue streams but also aligned them with the needs of various pharmaceutical innovators striving for precision and customization in their drug formulations. With a commitment to regulatory compliance and a robust infrastructural foundation, Neuland Laboratories continues to bolster its position in the market, marrying its time-honored expertise in chemistry with cutting-edge technological advancements to drive profitability and sustain its international footprint.

NEULANDLAB Intrinsic Value
8 141.62 INR
Overvaluation 40%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
16.4%
=
Operating Income
₹2.5B
/
Revenue
₹15.3B
What is Neuland Laboratories Ltd's current Operating Margin?

The current Operating Margin for Neuland Laboratories Ltd is 16.4%, which is below its 3-year median of 20.4%.

How has Operating Margin changed over time?

Over the last 3 years, Neuland Laboratories Ltd’s Operating Margin has increased from 12% to 16.4%. During this period, it reached a low of 12% on Sep 30, 2022 and a high of 27.4% on Mar 31, 2024.

Back to Top